• 263. Cytokines Everywhere All at Once: Approach to CRS and ICANS

  • Dec 15 2024
  • Durée: 17 min
  • Podcast

263. Cytokines Everywhere All at Once: Approach to CRS and ICANS

  • Résumé

  • Send us a text

    As a result of the rapid adoption CAR-T therapy for certain lymphoid malignancies and multiple myeloma, of these treatments, CRS and ICANS will become more common in IM wards in the coming years. Take a listen to learn about how to treat this emerging condition.

    This episode was written by Dr. Veronica Ramirez (Internal Medicine Resident) and reviewed by Dr. Kelly Davison (Hematology) and Dr. Blair Schwartz (General Internist and Intensivist). Infographic by Neeloufar Grami (medical student).

    Support the show

    Voir plus Voir moins

Ce que les auditeurs disent de 263. Cytokines Everywhere All at Once: Approach to CRS and ICANS

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.